Milestone Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Milestone Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.4M, a 51.3% decline year-over-year.
  • Milestone Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.18M, a 36.9% decline year-over-year.
  • Milestone Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.53M, a 5.37% increase from 2022.
  • Milestone Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.05M, a 24.3% increase from 2021.
  • Milestone Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.28M, a 47.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.53M +$486K +5.37% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $9.05M +$1.77M +24.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $7.28M +$2.33M +47.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $4.95M +$3.75M +315% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.19M +$558K +88.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $633K Jan 1, 2018 Dec 31, 2018 10-K/A 2020-10-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.